Clincosm LogoSign in Get a demo

Primary Myelofibrosis

Showing 26 - 50 of 99
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +61 more
May 5, 2022

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

Completed
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 27, 2022

Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis Trial in Worldwide (KRT-232, TL-895)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +36 more
May 5, 2022

Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],

Recruiting
  • Myeloproliferative Neoplasm
  • +5 more
  • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
  • Aspirin 81 mg
  • Ottawa, Ontario, Canada
    The Ottawa Hospital
Apr 19, 2022

Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

Recruiting
  • Primary Myelofibrosis
  • +9 more
  • Observational
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Feb 10, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +166 more
Jan 27, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2022

Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +22 more
Dec 7, 2021

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +121 more
Oct 21, 2021

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Duarte (procedure, drug, other)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Nov 2, 2021

Primary Myelofibrosis, Secondary Myelofibrosis, PMF Trial in Germany (INCB018424/CC-4047)

Active, not recruiting
  • Primary Myelofibrosis
  • +5 more
  • Aachen, Germany
  • +16 more
Sep 28, 2021

Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Rochester, Minnesota
    (unnamed)
Aug 24, 2021

Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • +7 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 14, 2021

A Prospective, Two-arm, Non-interventional Study of JAKAVI® in

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Jakavi
  • Aachen, Germany
    Novartis Investigative Site
Sep 6, 2021

Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Jul 9, 2021

Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Boston, Bronx, New

Completed
Has Results
  • Chronic Phase Myelofibrosis
  • +3 more
  • Boston, Massachusetts
  • +2 more
May 27, 2021

Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Farmington Hills, Sterling Heights

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Farmington Hills, Michigan
  • +1 more
Jun 5, 2021

Acute Megakaryoblastic Leukemia, Myelofibrosis, Primary Myelofibrosis Trial in Miami, Chicago, Rochester (Alisertib, Laboratory

Active, not recruiting
Has Results
  • Acute Megakaryoblastic Leukemia
  • +2 more
  • Miami, Florida
  • +2 more
May 4, 2021

Primary Myelofibrosis Trial (Pacritinib)

Withdrawn
  • Primary Myelofibrosis
  • Pacritinib
  • (no location specified)
May 3, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

    Withdrawn
    • Primary Myelofibrosis
    • +4 more
    • (no location specified)
    Mar 2, 2021

    Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary

    Recruiting
    • Myelofibrosis Transformation in Essential Thrombocythemia
    • +2 more
    • Elotuzumab
    • Questionnaire Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 17, 2021